Procter & Gamble Health Ltd - 500126 - Closure of Trading Window
We would like to inform you that the Trading Window of the Company shall remain closed for Directors and designated employees from April 1, 2023 until 48 hours from the publication of the unaudited financial results for quarter ended March 31, 2023 Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to regulation 39(3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015,we hereby inform you regarding issue of duplicate share certificate(s) to the shareholder(s) of the Company, on March 27,2023. We request you to take the same on record and acknowledge the receipt. Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by our Registrars and Share Transfer Agents (RTA), KFin Technologies Limited on March 25, 2023, regarding the loss /misplacement of the share certificate(s). We request you to take the same on record and acknowledge receipt. Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by our Registrars and Share Transfer Agents (RTA), KFin Technologies Limited on March 23, 2023, regarding the loss /misplacement of the share certificate(s) Procter & Gamble Health Ltd - 500126 - Organization Announcement -Allotment Of Director Identification Number To Mr. Lokesh Chandak- Additional Director (Executive) And Ms. Seema Sambasivan, Additional Director (Non- Executive)
We refer to our letter dated March 17,2023 pertaining to the appointments of Mr. Lokesh Chandak as Additional Director (Executive) and Ms. Seema Sambasivan, Additional Director (Non-Executive) effective April 01,2023 subject to date of allotment of Director Identification Number. We would like to inform you that, Mr. Lokesh Chandak has been allotted DIN - 10083315 by the Ministry of Corporate Affairs vide order dated March 21,2023 and Ms. Seema Sambasivan has been allotted DIN - 10085866 by the Ministry of Corporate Affairs vide order dated March 23,2023. Procter & Gamble Health Ltd - 500126 - Re-Appointment Of Mr. Milind Thatte (DIN 08092990) As The Managing Director Of The Company For A Period Of Five Years Effective April 1, 2023 - Shareholders' Approval
This has reference to our letter dated February 06,2023 regarding re-appointment of Mr. Milind Thatte (DIN 08092990) as the Managing Director of the Company for a period of five years effective April 1, 2023, subject to the approval of the Shareholders of the Company. We are pleased to inform you that the Shareholders' have, on March 22,2023 approved such re-appointment via Postal Ballot held by the Company, result of which has been declared today. Procter & Gamble Health Ltd - 500126 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
We are enclosing herewith following documents: 1. Proceedings of the Postal Ballot 2. Voting results in respect of the Postal Ballot process, as required under Regulation 44 of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015; and 3. Scrutinizers Report Kindly take the above on record and oblige. Procter & Gamble Health Ltd - 500126 - Shareholder Meeting / Postal Ballot-Outcome of AGM
We are enclosing herewith following documents: 1. Proceedings of the Postal Ballot 2. Voting results in respect of the Postal Ballot process, as required under Regulation 44 of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015; and 3. Scrutinizers Report Kindly take the above on record and oblige. Procter & Gamble Health Ltd - 500126 - Disclosure Of Voting Results Of The Postal Ballot Process
We are enclosing herewith following documents: 1. Proceedings of the Postal Ballot 2. Voting results in respect of the Postal Ballot process, as required under Regulation 44 of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015; and 3. Scrutinizers Report Kindly take the above on record and oblige. Procter & Gamble Health Ltd - 500126 - Organization Announcement- Appointment Of Chief Financial Officer
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of the Company, at its meeting held today, have appointed Mr. Lokesh Chandak as Chief Financial Officer effective April 1, 2023. A brief profile of Mr. Chandak is enclosed for your kind perusal. Kindly take the same on record and oblige.